A new CBO analysis estimated that the GOP-backed federal reconciliation package's language that delays or exempts certain orphan drugs from Medicare drug price negotiations could cost $8.8 billion over the next decade.
Language included in the recently enacted GOP-backed federal reconciliation package that delays or exempts certain orphan drugs from Medicare drug [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
